VISUfarma's established European operations will provide market expansion opportunities, direct presence and further business diversification across major European countries, including Italy, the UK, ...
Shares of Lupin are in focus on Monday morning after the pharma major said its wholly owned subsidiary, Nanomi BV, has signed a definitive agreement to acquire VISUfarma BV, a European specialty ...
Lupin’s subsidiary, Nanomi, has signed a definitive agreement for the acquisition of VISUfarma, a portfolio company of global healthcare specialist investor GHO Capital Partners. The acquisition of ...
Drug maker Lupin on Monday said its subsidiary has inked a pact to fully acquire Amsterdam-headquartered VISUfarma BV at an enterprise value of 190 million euros. The company’s wholly-owned subsidiary ...
Mumbai, London, Rome, Zug, September 29, 2025: Global pharma major Lupin Limited (Lupin), today announced its wholly owned subsidiary, Nanomi B.V. ('Nanomi'), has signed a definitive agreement for the ...
LONDON, ROME and ZUG, Switzerland, Sept. 29, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG ...
VISUfarma's established European operations will provide market expansion opportunities, direct presence and further business diversification across major European countries, including Italy, the UK, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results